ArticleAntibodies (Basel, Switzerland)2025

Survival Outcomes and Prognostic Factors in Rheumatoid Arthritis Patients Receiving Biologic or Targeted Synthetic Therapy: Real-World Data.

Zhaklin Apostolova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.